JPMorgan Reduces PT on The Chemours Company (CC) to $13 From $15, Keeps a Neutral Rating

The Chemours Company (NYSE:CC) is one of the best cheap small cap stocks to invest in now. On December 3, JPMorgan slashed the price target on The Chemours Company (NYSE:CC) to $13 from $15, maintaining a Neutral rating on the stock.

The rating update came after the company’s fiscal Q3 2025 earnings release on November 6, reporting that net sales for the quarter were $1.5 billion, flat compared to the prior-year quarter, driven primarily by a 3% decrease in volume, a 1% increase in price, and a 1% currency tailwind. The drop in volumes was attributed to operational impacts associated with the now resolved outage at APM’s Washington Works site, along with demand weakness in industrial end markets. Management stated that these trends were partially offset by the continued strength in TSS volumes, supported by the demand for Opteon™ Refrigerants.

The Chemours Company (NYSE:CC) further reported that adjusted EBITDA for fiscal Q3 2025 was $195 million, compared to $202 million in the prior year period, with the drop primarily driven by higher costs due to now resolved operational disruptions in the TT business and the previously referenced APM outage.

The company expects consolidated net sales to drop 10-15% sequentially in fiscal Q4 2025 due to seasonal impacts, and consolidated Adjusted EBITDA is expected to be in the range of $130 million and $160 million.

The Chemours Company (NYSE:CC) provides performance chemicals, delivering solutions that include a range of chemical and industrial products for markets, such as plastics, semiconductors and consumer electronics, coatings, transportation, refrigeration and air conditioning, and general industrial. The company operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Other.

While we acknowledge the potential of CC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.